WW International, Inc. (WW)
| Market Cap | 107.02M |
| Revenue (ttm) | 807.47M |
| Net Income (ttm) | -458.96M |
| Shares Out | 79.86M |
| EPS (ttm) | -5.78 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,524,778 |
| Open | 1.360 |
| Previous Close | 1.380 |
| Day's Range | 1.310 - 1.420 |
| 52-Week Range | 0.670 - 9.770 |
| Beta | 1.75 |
| Analysts | Buy |
| Price Target | 3.44 (+156.72%) |
| Earnings Date | Nov 6, 2024 |
About WW
WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other pe... [Read more]
Financial Performance
In 2023, WW International's revenue was $889.55 million, a decrease of -14.45% compared to the previous year's $1.04 billion. Losses were -$112.26 million, -56.30% less than in 2022.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for WW stock is "Buy." The 12-month stock price forecast is $3.44, which is an increase of 156.72% from the latest price.
News
WeightWatchers Unveils Next-Gen Program With AI-Powered App Features
With access to Registered Dietitians, 150+ New ZeroPoint® Foods and smarter tracking features, the new program delivers a cutting-edge, flexible approach to holistic weight management With access to R...
More turnover at the top, but this bull still believes in the Weight Watchers parent
D.A. Davidson reckons WW is a buy as its customers need more than a prescription.
WW International, Inc. Announces CFO Transition
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment of Felicia DellaFortuna as Chief Financial Of...
WW International, Inc. (WW) Q3 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW) Q3 2024 Results Conference Call November 6, 2024 8:30 AM ET Company Participants David Helderman - Vice President, Investor Relations Tara Comonte - Interim Preside...
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wed...
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs, a move that sent its shares soa...
WW Stock Rises as WeightWatchers Expands Drug Offerings
Shares of WW International Inc (WW, Financial) soared by 43.09% today due to the company's strategic move to expand its clinical weight management services. This expansion includes the introduction of...
WW International (WW) Surges After Adding Semaglutide to Weight Loss Program
WW International (WW, Financial) experienced a significant stock price increase, soaring 20.7% to $1.40. Early trading saw the stock rise as much as 46.5%.
WW International (WW) Surges After Introducing Compounded Semaglutide to Weight Loss Plans
WW International (WW, Financial), a provider of weight loss solutions, experienced a significant stock movement with an initial surge of over 46.5%, which later narrowed to around a 25% increase, reac...
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International (WW), better known as WeightWatchers, jumped nearly 25% Tuesday when the dieting services company announced it is offering a copycat version of blockbuster weight-loss drugs...
WeightWatchers' stock soars after adding compounded GLP-1 treatment to its offering
“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executi...
WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
WeightWatchers said on Tuesday it is adding a compounded version of Novo Nordisk's obesity drug Wegovy to its weight-management programs.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers CEO Sima Sistani is leaving the company
WeightWatchers CEO Sima Sistani is leaving the company after two and a half years. During that time, the company has radically altered its business model to stay competitive in the Ozempic era.
WW Parts Ways With President, CEO Sima Sistani
The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.
WeightWatchers Announces Executive Leadership Transition
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive Officer Sima Sistani Will Step Down as CEO and Director
WeightWatchers Announces Strategic Leadership Team Appointments
Additions of Chief Commercial Officer and Chief Impact Officer emphasize the Company's continued focus on growth ahead of 2025 Additions of Chief Commercial Officer and Chief Impact Officer emphasize ...
WW International: There May Never Be A Resurrection
WW International, Inc. stock has lost almost 80% of its value since my previous article in March 2023, which I published soon after the company announced the Sequence acquisition. Expansion into clini...
WW International, Inc. (WW) Q2 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW) Q2 2024 Earnings Call August 1, 2024 8:30 AM ET Company Participants Corey Kinger - Vice President, Investor Relations Sima Sistani - Chief Executive Officer Heathe...
WW International's stock falls toward a fresh record low after disappointing results, lowered outlook
Shares of WW International Inc., formerly known as Weight Watchers, dropped 1.9% into record-low territory, after the weight management company reported disappointing second-quarter results, lowered i...
WW International, Inc. Announces Second Quarter 2024 Results
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the second quarter of fiscal 2024.
WW International, Inc. Schedules Second Quarter 2024 Earnings Conference Call
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the second quarter 2024 before market open on Th...
WW International, Inc. (WW) Q1 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Corey Kinger - IR Sima Sistani - CEO Heather Stark - CFO Conference Call Participants J...
WW International, Inc. Announces First Quarter 2024 Results
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the first quarter of fiscal 2024.